Evidence map›Paper›PMID 18516665›Full record

ArticlePharmaceutical research2008

Injectable biodegradable polyurethane scaffolds with release of platelet-derived growth factor for tissue repair and regeneration.

Andrea E Hafeman, Bing Li, Toshitaka Yoshii, Katarzyna Zienkiewicz, Jeffrey M Davidson, Scott A Guelcher

Abstract read
In one paragraph

Article in Pharmaceutical research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 129 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Polymeric microcarriers for minimally-invasive cell delivery.Frontiers in bioengineering and biotechnology · 2023
    Review
  5. Review
  6. Article
  7. Dendritic cell biocompatibility of ether-based urethane films.Journal of applied toxicology : JAT · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Biomimetic polyurethane/TiOMaterials science & engineering. C, Materials for biological applications · 2018
    Article
  18. Article
  19. Article
  20. Injectable scaffolds: Preparation and application in dental and craniofacial regeneration.Materials science & engineering. R, Reports : a review journal · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Andrea E HafemanDepartment of Chemical Engineering, Vanderbilt University, Nashville, Tennessee, USA.
Bing Li
Toshitaka Yoshii
Katarzyna Zienkiewicz
Jeffrey M Davidson
Scott A Guelcher
Vanderbilt University · USVanderbilt University Medical Center · US

Funding

UV, APOPTOSIS, PROTEIN PHOSPHATASE AND SKIN DISEASEP30AR041943 · NIAMS · VANDERBILT UNIVERSITY · PI STRICKLIN, GEORGE PUTNAM · 1994 to 2008
$5.3M
NIAMS NIH HHS AR41943NIAMS NIH HHS P30 AR041943
6 · The paper itself

Abstract

purposeThe purpose of this work was to investigate the effects of triisocyanate composition on the biological and mechanical properties of biodegradable, injectable polyurethane scaffolds for bone and soft tissue engineering.

methodsScaffolds were synthesized using reactive liquid molding techniques, and were characterized in vivo in a rat subcutaneous model. Porosity, dynamic mechanical properties, degradation rate, and release of growth factors were also measured.

resultsPolyurethane scaffolds were elastomers with tunable damping properties and degradation rates, and they supported cellular infiltration and generation of new tissue. The scaffolds showed a two-stage release profile of platelet-derived growth factor, characterized by a 75% burst release within the first 24 h and slower release thereafter.

conclusionsBiodegradable polyurethanes synthesized from triisocyanates exhibited tunable and superior mechanical properties compared to materials synthesized from lysine diisocyanates. Due to their injectability, biocompatibility, tunable degradation, and potential for release of growth factors, these materials are potentially promising therapies for tissue engineering.

Indexed as

Absorbable ImplantsDrug CarriersTissue EngineeringTissue ScaffoldsAnimalsBiomechanical PhenomenaBone RegenerationCell LineCross-Linking ReagentsElasticityHydrolysisInjections, SubcutaneousIsocyanatesKineticsMaleMiceCross-Linking ReagentsDrug CarriersIsocyanatesPlatelet-Derived Growth FactorPolyurethanes

Identifiers

PMID18516665
PMCPMC3842433
OpenAlexW2024243970

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.